Korean guidelines for the prevention of venous thromboembolism

This guideline focuses on the primary prevention of venous thromboembolism (VTE) in Korea. The guidelines should be individualized and aim at patients scheduled for major surgery, as well as patients with a history of trauma, high-risk pregnancy, cancer, or other severe medical illnesses. Currently,...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Korean medical science 2010, 25(11), 144, pp.1553-1559
Main Authors: Bang, Soo-Mee, Jang, Moon Ju, Oh, Doyeun, Kim, Yeo-Kyeoung, Kim, In Ho, Yoon, Sung-Soo, Yoon, Hwi-Joong, Kim, Chul-Soo, Park, Seonyang
Format: Article
Language:English
Subjects:
Heparin, Low-Molecular-Weight - therapeutic use
Humans
Polysaccharides - therapeutic use
Republic of Korea
Risk Factors
Special
Venous Thromboembolism - prevention & control
Venous Thromboembolism - surgery
Venous Thromboembolism - therapy
Warfarin - therapeutic use
의학일반
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This guideline focuses on the primary prevention of venous thromboembolism (VTE) in Korea. The guidelines should be individualized and aim at patients scheduled for major surgery, as well as patients with a history of trauma, high-risk pregnancy, cancer, or other severe medical illnesses. Currently, no nation-wide data on the incidence of VTE exist, and randomized controlled trials aiming at the prevention of VTE in Korea have yielded few results. Therefore, these guidelines were based on the second edition of the Japanese Guidelines for the Prevention of VTE and the eighth edition of the American College of Chest Physicians (ACCP) Evidenced-Based Clinical Practice Guidelines. These guidelines establish low-, moderate-, and high-risk groups, and recommend appropriate thromboprophylaxis for each group.
ISSN:1011-8934
1598-6357
DOI:10.3346/jkms.2010.25.11.1553